Cardioline acquires Cardios to expand global telecardiology footprint

Backed by ARCHIMED, the deal strengthens connected cardiac diagnostics with integrated Holter, ABPM, and telemedicine solutions

Ferrotec launches fast & flexible DNA/RNA isolation kit aimed at streamlining lab workflows

Evonik and Higuchi launch “Open Pharma Lab” in Yokohama to accelerate oral drug Innovation

EUDRAGIT polymers remain a cornerstone technology in oral drug delivery

Kahimmune Therapeutics signs agreement for scientific collaboration with Gustave Roussy

Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights

Illuminova ’26 showcases AI-driven future of medical education at SRM

SRM Medical College Hospital and Research Centre hosts undergraduate research expo highlighting innovation, interdisciplinary collaboration, and the role of artificial intelligence

Exciva initiates Phase 2/3 SERENADA trial for Alzheimer’s agitation therapy

The company doses first patient in US study of Deraphan, as Dolby Ventures joins €53M Series B to support neuropsychiatric innovation

Cubo set to transform decentralised diagnostics with Compact RT-PCR innovation

Avio Smart Market Stack Limited and Huwel Lifesciences unveil portable, cost-efficient molecular testing platform

NADMED Limited appoints James Lee as CEO to drive global expansion

Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation

Laguna Diagnostics secures FDA breakthrough tag for mRNA test in psychiatric diagnosis

The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder

The next big opportunity lies in immune and rare disease white spaces: Venkat Nelabhotla, President & CEO, Vyome Holdings

With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints